Navigation Links
Paul Capital Healthcare Leads Panel on Strategic Financing
Date:6/8/2008

NEW YORK and LONDON, June 9 /PRNewswire/ -- Paul Capital Healthcare today announced that London-based partner Ken Macleod, Ph.D., will moderate a panel on strategic biotechnology financing at the BioFinance and BioInnovate Europe 08 conference. Designed to familiarize participants with how to use revenue streams as a strategic approach to financing, the panel, "Feeding the Beast: Structured Revenue Financing as a Strategy for Meeting Biotechnology's Capital Needs," is scheduled for 3:00 pm BST today. The conference, which is sponsored by the Biotechnology Industry Association, will be held at the Royal College of Physicians in London.

In addition to Dr. Macleod, the panel also will include Kristian Wiggert, Partner in the London office of Morrison & Foerster, and Steven Powell, Ph.D., Chief Executive Officer of Plethora Solutions Holdings PLC. Dr. Macleod will provide an overview and case studies of royalty and structured revenue financing transactions, Mr. Wiggert will discuss the legal considerations of these transactions and Dr. Powell will speak on the strategic rationale and mechanics of his company's recent revenue interest agreement with Paul Capital Healthcare.

"Structured revenue financing and royalty monetization transactions are becoming a standard financing strategy because they provide access to non- dilutive capital under flexible terms that can be structured to meet diverse objectives," said Dr. Macleod. "Companies and institutions can structure these transactions to provide capital for near-term initiatives while retaining a substantial portion of the long-term value and upside potential of their royalty and revenue streams. This panel presentation is designed to provide participants with real-life examples of how these transactions fit into an overall financial and asset management strategy and the opportunity to learn from those with first-hand knowledge of the process."

About Paul Capital Healthcare and Paul Capital Par
'/>"/>

SOURCE Paul Capital Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioSpace Releases the 2008 BioCapital(TM) Hotbed Campaign
2. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
3. CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference
4. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
5. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference
6. SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008
7. Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
8. MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments
9. Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
10. Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement
11. SPO Medical Retains American Capital Ventures for Investor Relations Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 On behalf of biotech ... companies, Wilentz, Goldman & Spitzer, P.A. (Wilentz) ... lawsuit against Genewiz Inc. in excess of $10 million. ... GenScript’s trade secrets, and that it improperly hired one ... an order denying motions for judgment notwithstanding the verdict, ...
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Already ... its gauging line by expanding its Length Gauge offerings ... ACANTO gauges. , Specifically, HEIDENHAIN’s pencil probe-style ... improved force specification. Two new 1Vpp, 12mm stroke ... lower force applications. One is a variant with a ...
(Date:2/26/2015)... Regis Technologies announced new potent compound ... substances. , Regis Technologies is proud to announce the ... Suite (PCS) for 2015. , Regis is a contract ... in Morton Grove, Illinois. The PCS addition will provide ... to about one kilogram per batch. , Regis’ ...
(Date:2/26/2015)...  Spark Therapeutics (NASDAQ: ONCE ) announced ... in the Cowen and Company Health Care Conference on ... the Boston Marriott Copley Place. To access ... the Cowen conference, please visit the "Upcoming Events" section ... Therapeutics website at www.sparktx.com .  A replay of ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Regis Extends cGMP Services to Oncology Market 2Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2
... HILL, N.C., Nov. 5 As biopharmaceutical,companies ... considerable efforts,are placed on strategy and execution ... focus on revenue growth and little else. ... excellence, a recent study,was conducted by Best ...
... - Phase II PC-DAC(TM):Exendin-4 Data in December - ... MONTREAL, Nov. 5 /PRNewswire-FirstCall/ - ConjuChem Biotechnologies,Inc. (TSX:CJB) ... Phase II,clinical trial of PC-DAC(TM):Exendin-4. This Phase II ... that,evaluated the efficacy and safety of three months ...
... BioMarin,Pharmaceutical Inc. (Nasdaq: BMRN ) today announced ... a company,update at the Credit Suisse 2008 Annual Healthcare ... 10:30 a.m. MST., Interested parties may access a ... section of the BioMarin website, http://www.BMRN.com .,A replay ...
Cached Biology Technology:New Study Provides Key Findings for Biopharma Product Launch Evaluation 2ConjuChem Provides Development Update 2ConjuChem Provides Development Update 3BioMarin to Present at the Credit Suisse Healthcare Conference 2
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source ... launch of its new website design. "When we ... infancy", says Peter O,Neill , founder and CEO of ... industry needs involvement from the key players on a very ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a leader ... announced the launch of a TR-FRET (time resolved ... Transcreener UDP Assay, a high throughput screening assay ... assay will allow for sensitive detection of hundreds ...
(Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... including technology and tech stocks, releases video from the CES ... and security consultant Apollo Robbins . Apollo ... the Wocket™ biometric smart wallet, a product of NXT-ID, Inc. ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... recent study to be published on April 27, 2011, in ... Hazen and colleagues found that oceanographic and prey measurements can ... team from Duke University, Woods Hole, and the Naval Undersea ... features and distributions of prey off the east coast of ...
... add new functions to stainless steel and make it ... by an interdisciplinary team at the University of Alberta ... was developed to address some of the problems associated ... body. Implanted biomedical devices, such as cardiac stents, ...
... CORVALLIS, Ore. - They can be both a blessing and a ... species are found from mountain tops to smoking volcanic vents on the ... to support much of the plant and animal life on Earth. ... And to a large extent, no one cared. Such has been the ...
Cached Biology News:Identifying beaked whale foraging habitat in the tongue of the ocean, Bahamas 2Sweet chemistry: Carbohydrate adhesion gives stainless steel implants beneficial new functions 2Research outlines mysterious evolution of nematodes -- one of Earth’s first animals 2Research outlines mysterious evolution of nematodes -- one of Earth’s first animals 3
Mouse monoclonal [X223] to Lamin B1 + B2 - Nuclear Envelope Marker ( Abpromise for all tested applications). entrezGeneID: 4001 SwissProtID: P20700...
odz, odd Oz/ten-m homolog 1 [Source:RefSeq_peptide;Acc:NP_055068] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit polyclonal to NIRF ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from residues 186-235 of human NIRF. Entrez Gene ID: 115426 Swiss Protein ID: Q96PU...
Rabbit polyclonal to ZNF261 ( Abpromise for all tested applications). entrezGeneID: 9203 SwissProtID: Q14202...
Biology Products: